Dr. Michael Greicius, from the Stanford Center for Memory Disorders, Department of Neurology and Neurological Sciences, Stanford University School of Medicine is conducting a study using healthy ApoE4 carriers to identify genetic influences on the development of Alzheimer’s Disease to aid in better understanding and treating the disease.
Eligible individuals with one copy of the ApoE4 allele must be over the age of 70 (if female) or over the age of 75 (if male). Individuals with two copies of the ApoE4 allele must be over the age of 65. Participants must have no history of memory loss or neurological illness, no heart or vascular implants, and must be able to lay flat for a MRI scan.
The study involves brain imaging (MRI), genetic testing, memory testing, a blood draw, and a spinal fluid draw. All procedures will be performed at the Stanford University Medical Center. Participation will involve 1 full day and 1 half day of participation. These visits may be spread out over a range of 2 months.
To learn more, please see the PDF below or contact: Sarah Schlegel email@example.com
/ (650) 724-3747
You do not have the required permissions to view the files attached to this post.